Table 1 Characteristics of Study Subjects
Cases (n = 45) | Controls (n = 45) | |
|---|---|---|
Age at blood draw, years | 52.4 (26–80) | 53 (36–73) |
Age at diagnosis, years | 58.8 (30–84) | N/A |
Post-menopausal at blood draw, % | 58 | 60 |
Number of affected first-degree relatives, % | ||
1 | 29 | 31 |
2 | 29 | 27 |
3 | 42 | 42 |
BRCA1 Mutation, % | ||
Positive | 7 | 9 |
Negative | 20 | 13 |
Unknown | 73 | 78 |
BRCA2 Mutation, % | ||
Positive | 2 | 11 |
Negative | 11 | 9 |
vUnknown | 87 | 80 |
Estrogen Receptor Status, % | ||
Positive | 51 | – |
Negative | 22 | - |
Unknown | 27 | |
Progesterone Receptor Status, % | ||
Positive | 53 | – |
Negative | 20 | - |
Unknown | 27 | |
Human Epidermal Growth Factor Receptor 2 Status, % | ||
Positive | 9 | - |
Negative | 60 | – |
Unknown | 31 | |
Summary Stage, % | ||
Localized | 20 | – |
Regional, nodes only | 11 | – |
Unknown | 69 | |